Advertisement

Topics

Blue Earth Diagnostics Announces Fluciclovine F 18 Presentations at Upcoming Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting

08:00 EDT 6 Jun 2017 | Businesswire
This article has expired, however you can still download the PDF.
Preview:
Blue Earth Diagnostics, a molecular imaging diagnostics company, today announced that several presentations related to fluciclovine F 18 injection will be occurring at the Society of Nuclear Medicine and Molecular Imaging Annual...

Other Sources for this Article

For Blue Earth Diagnostics (U.S.)
Priscilla Harlan
Vice President, Corporate Communications
(M) 781-799-7917
p.harlan@blueearthdx.com
or
Media
Sam Brown Inc.
Mike Beyer
(M) 312-961-2502
mikebeyer@sambrown.com
or
For Blue Earth Diagnostics (UK)
Val Jones PR Ltd
Dr. Val Jones
(M) +44 (0) 7917 175 192
v.jones@blueearthdx.com

NEXT ARTICLE

More From BioPortfolio on "Blue Earth Diagnostics Announces Fluciclovine F 18 Presentations at Upcoming Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting"

Quick Search
Advertisement
 

Relevant Topics

Clinical Research Organization
Contract Research Organization (CRO) provide research services outsourced on a contract basis to the pharmaceutical, biotechnology, healthcare and medical device industries: biopharmaceutical development biologic assay development commercial...

Biological Therapy
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...